Search Results - Adeline Morel
- Showing 1 - 4 results of 4
-
1
Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy by Charline Lasnon, Adeline Morel, Nicolas Aide, Angélique Da Silva, George Emile
Published in Cancer Imaging (2024-07-01)Get full text
Article -
2
Does COVID‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital by Florian Quilan, Justine Lequesne, François Cherifi, Etienne Bastien, Adeline Morel, Corinne Delcambre, Angélique Da Silva, Jean‐Michel Grellard, Alexandra Leconte, Audrey Faveyrial, Bénédicte Clarisse, Florence Joly
Published in Cancer Medicine (2023-09-01)Get full text
Article -
3
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors by Pauline Rottier, George Emile, George Emile, Alison Johnson, Alison Johnson, Christelle Levy, Djelila Allouache, Ioana Hrab, Carine Segura, Adeline Morel, Maud Villemin, Coraline Dubot-Poitelon, Louis Boismoreau, François Cherifi, Justine Lequesne, Angélique Da Silva
Published in Frontiers in Oncology (2023-01-01)Get full text
Article -
4
Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study by François Gernier, Jean-Michel Grellard, Charlotte Dupont, Hervé Castel, Marie Fernette, François Lahaye, Rose-Marie Charles, Tiphaine Leroux, Céline Ory, Audrey Faveyrial, Adeline Morel, George Emile, Christelle Levy, Carine Segura, Djelila Allouache, Alison Johnson, Julien Geffrelot, Katharina Gunzer, Anaïs Lelaidier, Gilles Girault, Coraline Dubot-poitelon, Chankannira San, Justine Lequesne, Bénédicte Clarisse
Published in BMC Cancer (2023-08-01)Get full text
Article